Evidence map›Paper›PMID 38771152›Full record

ArticleJMIR research protocols2024

Combination of Curcuminoids and Acupressure for Inflammation and Pain in Older People with Osteoarthritis Genu: Protocol for a Randomized Controlled Trial.

Srinalesti Mahanani, Nyoman Kertia, Ema Madyaningrum

2 registry-linked trialsAbstract readClinical Trial Protocol
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06105840 phase1 / phase2unknown statusnot on this map

Effect of Combination of Curcuminoid Standardized Turmeric Extract With Acupressure on Inflammatory Markers, Endorphins and Quality of Life in Elderly People With Osteoarthritis Genu

TypeinterventionalSponsorGadjah Mada UniversityRan2023 to 2023Enrolled70ConditionsOsteoarthritis, KneeArmsAcupressure and Standardized Curcuminoid from Turmeric Extract, Sham Acupressure and Placebo
NCT07183215 phase2 / phase3enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Efficacy Test of Curcuminoid Standardized Turmeric Capsules to Improving Inflammatory Biomarkers in Osteoarthritis Genu

TypeinterventionalSponsorGadjah Mada UniversityRan2025 to 2025Enrolled72ConditionsOsteoarthritisArmsCurcuminoid Standardized Turmeric Capsules, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Srinalesti MahananiDoctorate Program of Medical and Health Science, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.ORCID 0000-0002-2754-9648
Nyoman Kertia *Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.ORCID 0009-0005-5319-945X
Ema MadyaningrumDepartment of Mental and Community Health Nursing, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.ORCID 0000-0002-1811-5055

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurcuminoids and acupressure have beneficial effects in reducing pain and inflammation in patients with osteoarthritis. However, only a few clinical trials are investigating biomarkers to prove this objectively.

objectiveThis study aims to investigate the effect of acupressure and curcuminoids on inflammatory markers and pain in older people with osteoarthritis genu.

methodsA randomized controlled trial (RCT) was conducted among older people with osteoarthritis. All participants were randomized to a group that received 30 mg of curcuminoids in turmeric extract capsules and acupressure (group 1) or a group that received a placebo and sham acupressure (group 2) for 3 weeks.

resultsThe study was approved by the research ethics board; ClinicalTrials.gov reviewed this protocol. The extracts were manufactured from May 2023 to June 2023. Participant recruitment was conducted in September and October 2023; a total of 72 participants aged 60 years or older participated, of whom 75% (n=54) were female. Data were analyzed in April 2024, and dissemination of results is expected by the end of 2024.

conclusionsPrimary outcomes were assessed at baseline and after the intervention. Relationships were assessed with inflammatory markers, endorphin hormones, and blood level of cycloxygenase-2 hormone. Additionally, secondary outcomes included pain, ability to perform activities of daily living, and quality of life. The beneficial effects that may be found in this trial may be exceptionally relevant in clinical practice, justifying this scientific inquiry. The benefits of herbs and acupressure can be helpful as additional options in treating inflammation and pain in patients with osteoarthritis.

trial registrationClinicalTrials.gov NCT06105840; https://clinicaltrials.gov/study/NCT06105840. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/54970.

Indexed as

AcupressureInflammationOsteoarthritisAgedCombined Modality TherapyFemaleHumansMaleMiddle AgedPain ManagementRandomized Controlled Trials as Topicacupressurebiomarkerscurcuminoidsendorphinsgenuolder peopleosteoarthritisrandomized controlled trial

Identifiers

PMID38771152
PMCPMC11231618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.